# DEFERASIROX

NDC: 62332-412
Generic name: DEFERASIROX
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20191121

FDA application: ANDA211824

## Active ingredients

- DEFERASIROX: 360 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-412"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-412
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1f952c8-89f5-4a2f-bd6b-9b384366d971